Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Transplantation

Negative vaccination to modulate transplant immunity

Ezzelarab et al. report that regulatory dendritic cells administered prior to transplantation modulate alloimmunity and increase kidney allograft survival. This finding provides the first evidence of the immunosuppressive efficacy of modified dendritic cells in a stringent pre-clinical primate model, offering hope that long-term immunosuppression of transplant recipients could be minimized or avoided.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: How DCREG regimen components can influence immune outcomes.

References

  1. Ezzelerab M. B. et al. Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am. J. Transplant. 13, 1989–2005 (2013).

    Article  Google Scholar 

  2. Steinman R. M. & Banchereau, J. Taking dendritic cells into medicine. Nature 449, 419–426 (2007).

    Article  CAS  Google Scholar 

  3. Tacken, P. J., de Vries, I. J., Torensma, R. & Figdor, C. G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790–802 (2007).

    Article  CAS  Google Scholar 

  4. Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H. & Jonuleit, H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80, 477–483 (2002).

    Article  Google Scholar 

  5. Coates, P. T., Colvin, B. L., Hackstein, H. & Thomson, A. W. Manipulation of dendritic cells as an approach to improved outcomes in transplantation. Expert Rev. Mol. Med. 4, 1–21 (2002).

    Article  Google Scholar 

  6. Zahorchak, A. F. et al. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 84, 196–206 (2007).

    Article  CAS  Google Scholar 

  7. Wojciechowski, D. & Vincenti, F. Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update. Biologics 6, 385–393 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Morelli, A. E. & Thomson, A. W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610–621 (2007).

    Article  CAS  Google Scholar 

  9. Levitsky, J. et al. Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans. Transplantation http://dx.doi.org/10.1097/TP.0b013e31829f1607.

  10. Lo, D. J. et al. Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am. J. Transplant. 13, 320–328 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan S. Bromberg.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azimzadeh, A., Bromberg, J. Negative vaccination to modulate transplant immunity. Nat Rev Nephrol 9, 557–559 (2013). https://doi.org/10.1038/nrneph.2013.172

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2013.172

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing